Novartis Seeks To Block Rival's Generic Blood Pressure Drug
Novartis has asked a London court to halt a competitor's plans to sell a generic version of its blood pressure medication, arguing that a replica drug will infringe its extended patent...To view the full article, register now.
Already a subscriber? Click here to view full article